Ursolic Acid: Benefits, Sources, and Side Effects

A guide to ursolic acid, a plant compound studied for its role in muscle and metabolism, highlighting current research and practical considerations.

Ursolic acid is a plant-derived compound that has generated significant research interest for its effects on muscle, metabolism, inflammation, and more. Found naturally in apple peels, rosemary, thyme, and dozens of other plants, it belongs to a class of molecules called pentacyclic triterpenoids. Most of its impressive-sounding benefits come from animal and cell studies, though, and a stubborn bioavailability problem limits how much your body actually absorbs when you eat it. That gap between laboratory promise and real-world usefulness is what makes ursolic acid such a fascinating and frustrating compound to evaluate.

Where Ursolic Acid Shows Up in Your Diet

Apple peels are the most commonly cited dietary source, and the one most people encounter without thinking about it. But ursolic acid is widespread across the plant kingdom. It appears in culinary herbs like thyme, oregano, rosemary, and sage, as well as in holy basil, hawthorn berries, and the flowers of frangipani (Plumeria rubra). The waxy coating on fruit skins tends to concentrate the compound, which is part of why apple peel gets highlighted so often. However, the amounts in a typical serving of any food are small compared to the doses used in research, so eating a few apples a day is not going to replicate what happens in a lab study using purified ursolic acid.

Why Your Body Barely Absorbs It

Ursolic acid’s biggest practical limitation is that it is poorly absorbed when taken by mouth. It dissolves poorly in water, passes through the gut lining inefficiently, and gets broken down by liver enzymes before much of it reaches the bloodstream. Pharmacologists classify it as a “BCS IV” drug, meaning it scores low on both solubility and permeability. After oral dosing in animal studies, blood levels peak quickly, within about half an hour, but the absolute amount that reaches circulation is low.

Researchers have tried several workarounds. Liposomes, nanoparticles, solid dispersions, and co-formulations with piperine (the compound in black pepper that inhibits certain liver enzymes) have all shown improvements in cell and animal models. None of these delivery strategies have been widely adopted in over-the-counter supplements yet, so the ursolic acid capsules you find on store shelves may deliver far less to your bloodstream than the dose listed on the label would suggest. This is worth keeping in mind whenever you see impressive results from a study: the researchers likely used either high-dose injections or specially engineered formulations that bypass the absorption problem entirely.

Muscle Mass, Strength, and Exercise

The finding that first put ursolic acid on the fitness community’s radar came from a widely cited mouse study. Researchers screened gene expression patterns in atrophying human muscle, identified molecular signatures associated with wasting, and then looked for compounds that could reverse those patterns. Ursolic acid emerged as the top candidate. In mice, it boosted activity in the insulin and IGF-1 signaling pathways that promote muscle growth while suppressing genes linked to atrophy. Follow-up work from the same lab showed that ursolic acid increased skeletal muscle mass, enlarged both fast-twitch and slow-twitch muscle fibers, improved grip strength, and raised exercise capacity in mice. It also increased brown fat, the metabolically active fat tissue that burns calories, while reducing diet-induced obesity and fatty liver.

A systematic review of the animal literature confirmed that these effects involve multiple overlapping mechanisms, including increased circulating growth hormone and IGF-1, activation of protein-synthesis pathways, and inhibition of proteins that break muscle down.

The only human exercise trial currently available is small. In a pilot study, 16 resistance-trained men were split into two groups, with half receiving 450 mg of ursolic acid daily alongside their training program for eight weeks. The supplemented group showed lower blood markers of muscle damage, including creatine kinase and lactate dehydrogenase, compared to the training-only group. That is an encouraging signal, but eight men per group is too few to draw firm conclusions about muscle growth or performance gains. The muscle-building story remains mostly an animal-data story for now.

Metabolic Effects and Body Weight

Beyond muscle, ursolic acid appears to influence blood sugar regulation and body composition in animal studies. In fat cells, it promotes glucose uptake through the same insulin-signaling pathway that medications like metformin partially rely on, increasing the movement of glucose transporters to the cell surface. In diabetic mice, it has reduced liver weight and markers of liver damage, effects attributed to enhanced fat burning in the liver and reduced cellular stress. Additional animal work has shown that ursolic acid slows the progression from fatty liver to more advanced liver disease, including the inflammatory and fibrotic stages that can eventually lead to liver cancer.

One small human trial offers a glimmer of clinical translation. Researchers gave ursolic acid to patients with metabolic syndrome and reported that half achieved remission of the syndrome, with reductions in body weight, waist circumference, fasting glucose, and improvements in insulin sensitivity. Those are meaningful changes, but the authors themselves described the remission as “transient,” and the trial was not large or long enough to determine lasting effects. It is a proof-of-concept result, not a treatment recommendation.

Anti-Inflammatory and Antioxidant Activity

Ursolic acid dials down inflammation through several converging routes. In cartilage cells stimulated with an inflammatory signal, it reversed the surge of destructive enzymes and inflammatory molecules and blocked a key inflammatory signaling cascade. In a rat model of osteoarthritis, this translated into measurable protection of joint cartilage. Separately, cranberry extracts rich in ursolic acid and its derivatives inhibited cyclooxygenase-2 (the enzyme targeted by anti-inflammatory drugs like ibuprofen) and reduced the release of multiple inflammatory cytokines from human immune cells exposed to bacterial toxins.

On the antioxidant side, a meta-analysis pooling results from animal studies found that ursolic acid significantly raised levels of the body’s built-in antioxidant defenses, including superoxide dismutase and glutathione, while lowering malondialdehyde, a marker of oxidative damage to fats. Those effects were consistent across a range of disease models, suggesting that the antioxidant activity is a fairly robust feature of the compound rather than an artifact of one particular experimental setup.

Cancer Research in Preclinical Models

Ursolic acid has been tested against numerous cancer cell lines and tumor models. It inhibits tumor growth in animals through a combination of mechanisms: triggering programmed cell death in cancer cells, cutting off the blood vessel growth that tumors need to sustain themselves, and arresting the cell cycle so cancer cells stop dividing. In a breast cancer mouse model, it reduced primary tumor growth and decreased the number of metastatic lesions in the lungs.

A Phase I clinical trial tested an intravenous liposomal formulation of ursolic acid in 21 patients with advanced solid tumors. The trial’s purpose was safety evaluation, not cure, and on that front the results were encouraging: no severe adverse events occurred across the dose levels tested, and about 60% of patients achieved stable disease (meaning tumors did not grow further) after two treatment cycles. “Stable disease” is not tumor shrinkage, and 21 patients is a very small group, so this falls far short of establishing ursolic acid as a cancer treatment. But it does suggest the compound is tolerable at therapeutic doses and worth investigating further in larger trials.

Neuroprotection and Cognitive Health

A growing body of animal research examines ursolic acid’s effects in the brain. A review of the evidence described its potential across conditions including traumatic brain injury, stroke, anxiety, depression, and general cognitive decline, with antioxidant and anti-inflammatory mechanisms underpinning most of the observed effects.

More specifically, ursolic acid protected neurons in a rat model of epilepsy by restoring mitochondrial function and reducing oxidative damage in the hippocampus, the brain region most critical for memory. In another study, rats given a bacterial toxin to mimic brain inflammation showed learning and memory deficits that ursolic acid partially reversed, with higher doses (100 mg/kg) working better than lower ones. The compound calmed overactive immune cells in the brain and dampened inflammatory signaling. No human trials have tested ursolic acid for cognitive or neurological outcomes, so these results remain squarely in the preclinical stage.

Skin and Cosmetic Uses

Ursolic acid has carved out a quieter niche in the skincare world. Two related studies demonstrated that when ursolic acid is encapsulated in liposomes and applied topically, it increases ceramide content in skin cells and collagen production in dermal fibroblasts. Ceramides are waxy lipids that form the skin’s moisture barrier, and their decline with age contributes to dryness and wrinkling. In human volunteers, the liposomal formulation raised skin ceramide levels within just three days of application. Researchers compared its effects to retinoids, the gold-standard anti-aging ingredient in dermatology, concluding that ursolic acid liposomes had similar effects on keratinocyte differentiation and collagen synthesis.

This is one area where the bioavailability problem matters less, since the compound is applied directly to the target tissue rather than relying on gut absorption and blood transport. Several cosmetic products already include ursolic acid as an active ingredient, and patented formulations exist for topical use. Whether ursolic acid creams compete with established retinoid products in long-term clinical outcomes remains untested, but the early data on ceramide and collagen effects is more than just marketing hype.

Effects on Gut Bacteria

A more recent line of research connects ursolic acid to the gut microbiome. In a rat model of nerve injury pain, ursolic acid shifted the composition of gut bacteria, with notable changes in several bacterial genera. The researchers proposed that these microbiome changes contributed to its pain-relieving effects, working alongside direct anti-inflammatory activity in the nervous system. In a colitis model, ursolic acid rebalanced the immune response in the gut, boosted populations of beneficial short-chain-fatty-acid-producing bacteria, inhibited the growth of harmful E. coli through a microbial metabolite, and strengthened the intestinal barrier.

The idea that ursolic acid’s poor absorption might actually work in its favor in the gut, since the compound stays in contact with intestinal bacteria rather than being whisked into the bloodstream, is speculative but intriguing. This area is young, and researchers are still working out which effects are caused directly by ursolic acid and which are downstream consequences of the microbial shifts it triggers.

Safety, Side Effects, and Dose-Limiting Toxicity

In animal studies, ursolic acid has a reassuring safety profile at oral doses. A rodent study using an extremely high single oral dose of 12,500 mg per kilogram found no deaths or clinical signs of toxicity. When male rats received 250 mg per kilogram daily for 30 days, sperm quality, testicular structure, and overall health were unaffected. Those are substantial doses relative to body weight, suggesting a wide safety margin for oral consumption.

When given intravenously as liposomes to humans in the Phase I cancer trial, the picture gets more nuanced. The dose-limiting side effects were liver toxicity (elevated liver enzymes) and diarrhea, which appeared at higher infusion doses. Milder side effects included nausea, abdominal bloating, a mild skin rash, and minor irritation at the infusion site. These side effects were tied to an intravenous formulation designed for cancer treatment, not to the kind of oral supplement a consumer would buy. Still, the liver toxicity finding is worth noting because it suggests that at high enough systemic exposures, ursolic acid is not entirely benign.

For supplement users, the practical risks are probably low given how little gets absorbed orally. But that same poor absorption makes it hard to say whether a lack of reported side effects reflects true safety or simply the fact that not enough reaches the bloodstream to cause trouble. If future delivery technologies dramatically improve absorption, the safety equation could change.

The Gap Between Animal Data and Human Proof

The honest summary of ursolic acid’s evidence base is that it has a deep pile of animal and cell-culture data and a very thin stack of human trials. The metabolic syndrome study found real changes in weight, glucose, and insulin sensitivity, but in a small group with transient results. The cancer trial confirmed safety but was not designed to test effectiveness. The resistance-training pilot was encouraging but had only eight people per group. Everything else, the neuroprotection, the cancer cell killing, the anti-inflammatory pathways, the gut microbiome effects, exists entirely in animal and test-tube experiments.

That does not mean these findings are wrong. Many compounds that work in mice eventually work in humans. But many others do not, and the history of natural-product research is littered with molecules that looked spectacular in rodents and flopped in clinical trials. Ursolic acid’s bioavailability problem compounds the uncertainty: even if the compound genuinely has these effects at the cellular level, getting enough of it into human tissues through an oral capsule is an unsolved engineering challenge. Researchers continue working on liposomal formulations, nanocrystals, and co-amorphous preparations to bridge this gap, but for now the supplement aisle is well ahead of the clinical evidence.

Ursolic Acid in Commercial Products

Despite the limited human data, ursolic acid already appears in a range of consumer products. In supplements, it is sold as a standalone ingredient, often marketed to bodybuilders and fitness enthusiasts, and as part of herbal blends. Doses on supplement labels typically range from 150 to 450 mg per day, though how much gets absorbed is unknown for most commercial formulations. In cosmetics, it is used in anti-aging serums and creams, where direct skin application sidesteps the oral absorption problem. Various patented extraction and formulation technologies have been developed for both pharmaceutical and cosmetic applications, using techniques ranging from ultrasound-assisted extraction to supercritical fluid methods to obtain higher-purity ursolic acid from plant material.

Ursolic acid is not an approved drug in any country. In the United States, it falls under the umbrella of dietary supplements, which means manufacturers can sell it without proving effectiveness and without pre-market approval from the FDA. Quality and purity of supplement products can vary widely. If you are considering a ursolic acid supplement, look for products that provide third-party testing certificates, and keep your expectations calibrated to the evidence: interesting but preliminary for most claimed benefits, with the topical skin application being the area where the gap between lab data and real-world results is smallest.